The known prognostic factors of endometrial carcinoma include degree of tumor differentiation, International Federation of Gynecology and Obstetrics (FIGO) stage, histologic type, and estrogen receptor (ER) positivity [4–6], but do not predict patient outcome or guide treatment. This evidence concerns the gene ESR1 and neoplasm.